Jubelirer Steven J, Arden Donna, Jones James W
CAMC Health Education and Research Institute, Charleston, USA.
W V Med J. 2005 Nov-Dec;101(6):256-7.
Patients with clotting disorders, including hemophilias A and B, and von Willebrand Disease generally receive pooled human blood products, and are at high risk for HIV-1 and hepatitis A, B and C viral infection. This retrospective study describes patients receiving treatment at a federally funded Hemophilia Treatment Center (HTC) from 1998 - 2002 and assesses the prevalence of viral infection. In addition, current rates of viral infection are compared to 1984-1996 rates.
患有凝血障碍的患者,包括甲型和乙型血友病以及血管性血友病,通常会接受混合人血制品治疗,他们感染HIV-1以及甲型、乙型和丙型肝炎病毒的风险很高。这项回顾性研究描述了1998年至2002年期间在一家由联邦政府资助的血友病治疗中心(HTC)接受治疗的患者,并评估了病毒感染的患病率。此外,还将当前的病毒感染率与1984年至1996年的感染率进行了比较。